427 search results for “war on drug” in the Student website
- Listen to the new Studenticast on Drug use
-
Mini organs-on-chips: an alternative to drug testing on animals
Mini organs-on-chips allow us to study how diseases develop and how drugs work. Although the technology is not new, it is becoming increasingly advanced. PhD candidate Bart Kramer hopes it will eliminate animal testing in the future.
-
LACDR launches training programme for innovative drug development
The Leiden Academic Centre for Drug Research (LACDR) has received a €750,000 grant from ZonMw for QPharmNL. This is a continuing education programme that trains professionals in computational techniques in pharmacology for innovative drug development.
-
Martijn KitzenFaculty of Governance and Global Affairs
m.w.m.kitzen@fgga.leidenuniv.nl | 070 8009500
-
Hildert BronkhorstFaculty of Science
h.bronkhorst@biology.leidenuniv.nl | +31 71 527 4964
-
A faster way to find new medicines – without the limitations of big DNA barcodes
Leiden researchers, led by Sebastian Pomplun developed a new method to screen hundreds of thousands of molecules for drug discovery, using mass spectrometry instead of DNA tags. ‘We wanted to make drug discovery faster and more accessible.’
-
Frans OsingaFaculty of Governance and Global Affairs
f.p.b.osinga@fgga.leidenuniv.nl | +31 70 800 9506
-
Peter BouwmanFaculty of Science
r.j.p.bouwman@lacdr.leidenuniv.nl | 071 5276105
-
Artificial intelligence as the co-pilot for drug discovery
There are more molecules that could conceivably be candidate drugs than there are stars in the universe. How can we ever efficiently identify those molecules? Professor of AI and Medicinal Chemistry, Gerard van Westen: ‘I’m going to use artificial intelligence as the co-pilot to make an automated search.’…
-
Giulia CallegaroFaculty of Science
g.callegaro@lacdr.leidenuniv.nl | 071 5276105
-
market needs: new course for master’s students focuses on quality in drug development
Immediately connect with the needs of industry with your master’s degree. The new course Practical Aspects of Quality Management in Pharma and Biotech provides just that. The LACDR and LUMC set up the course together with the Biotech Training Facility, located at the Leiden Bio Science Park. The first…
-
Bob van de WaterFaculty of Science
water_b@lacdr.leidenuniv.nl | +31 71 527 6223
-
Maria Amjad
Social & Behavioural Sciences
m.amjad@fsw.leidenuniv.nl | 071 5272727
-
Eani LachmansinghFaculty of Science
e.t.lachmansingh@liacs.leidenuniv.nl | 071 5272727
-
Roos van der Haer
Social & Behavioural Sciences
r.van.der.haer@fsw.leidenuniv.nl | +31 71 527 3886
-
Leiden-developed drug candidate ready for final clinical trial phase
Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.
-
Bart SchuurmanFaculty of Governance and Global Affairs
b.w.schuurman@fgga.leidenuniv.nl | +31 70 800 9347
-
Silvia D'AmatoFaculty of Governance and Global Affairs
s.damato@umail.leidenuniv.nl | 070 8009506
-
New potential cancer drugs and where to find them
Cancer research generates massive amounts of data, but traditional tools often fail to fully harness their potential. How can we unlock this data to provide better treatments for cancer patients? PhD candidate Marina Gorostiola González explored this by using advanced data analysis techniques to guide…
-
Countering nerve pain caused by chemotherapy with new drug
Nerve pain is one of the most common side effects of chemotherapy. It is therefore one of the biggest reasons for cancer patients to stop treatment early. Darcy Reynolds worked on new drug candidates against this pain during her bachelor's thesis. She developed a new series of molecules that increase…
-
Alexander KrosFaculty of Science
a.kros@chem.leidenuniv.nl | +31 71 527 4234
-
Gerard van WestenFaculty of Science
gerard@lacdr.leidenuniv.nl | +31 71 527 3511
-
Bart van der BoomFaculty of Humanities
b.e.van.der.boom@hum.leidenuniv.nl | +31 71 527 2762
-
Catherine WoodFaculty of Humanities
c.m.wood@hum.leidenuniv.nl | +31 71 527 7177
-
Anneleen van der MeerFaculty of Governance and Global Affairs
a.van.der.meer@fgga.leidenuniv.nl | +31 70 800 9506
-
Anais van ErtveldeFaculty of Humanities
a.e.van.ertvelde@hum.leidenuniv.nl | +31 71 527 1646
-
Lukas MilevskiFaculty of Humanities
l.milevski@hum.leidenuniv.nl | +31 71 527 1288
-
Roxanne KieltykaFaculty of Science
r.e.kieltyka@chem.leidenuniv.nl | +31 71 527 4441
-
Eline DekeysterSocial & Behavioural Sciences
e.a.g.dekeyster@fsw.leidenuniv.nl | +31 71 527 2727
-
Laura HeitmanFaculty of Science
l.h.heitman@lacdr.leidenuniv.nl | +31 71 527 4558
-
Thijs Brocades ZaalbergFaculty of Humanities
t.w.brocades.zaalberg@hum.leidenuniv.nl | 071 5272770
-
William Michael SchmidliFaculty of Humanities
w.m.schmidli@hum.leidenuniv.nl | +31 71 527 2341
-
Drugs with fewer side effects through a collaboration between LACDR and PTS
LACDR, the Leiden Institute for Drug Research, developed better tolerated excipients to prevent adverse effects related to the surface of nanosized drugs such as vaccines. LADCR professor of Biopharmacy Matthias Barz and Polypeptide Therapeutic Solutions (PTS) are collaborating to develop processes…
-
Seeking new concepts to treat diseases
Scientific Director of the Leiden Academic Centre for Drug Research (LACDR) Hubertus Irth: ‘We test substances and look for new concepts for treating disease.’
-
Love, war and... football: 2024 in Leiden stories
A new government, conflicts around the world and obviously a lot of science: these are the five stories about Leiden University that you enjoyed reading in 2024.
-
Arteriosclerosis and drug discovery: two young researchers win Krijn Rietveld Award for innovative research
One discovered that arteriosclerosis resembles an autoimmune disease, while the other developed a system to aid in the search for new medications. For these achievements, Marie Depuydt and Jurren de Groot were awarded the Krijn Rietveld Memorial Innovation Award on the evening of Tuesday 4 June.
-
Eamon AloyoFaculty of Governance and Global Affairs
e.t.aloyo@fgga.leidenuniv.nl | +31 70 800 9195
-
‘We’re already at war – we’re just acting as though we’re not’
Professor of International Relations Daniel Thomas is clear: anyone taking peace in Europe for granted is shutting their eyes to reality.
-
Man-made antibodies may change the future of drug development – here’s why
Sometimes an idea seems so logical and elegant at first glance, that you later wonder why no one thought of it before. Two researchers from LACDR have teamed up to develop a completely synthetic alternative to antibodies—one that mimics their size, shape and function, but which is cheaper, more stable,…
-
Madeline KavanaghFaculty of Science
m.e.kavanagh@lic.leidenuniv.nl | 071 5272727
-
Giles Scott-SmithFaculty of Governance and Global Affairs
g.p.scott-smith@luc.leidenuniv.nl | +31 70 800 9503
-
Mario van der SteltFaculty of Science
m.van.der.stelt@chem.leidenuniv.nl | +31 71 527 4768
-
Margo DonaFaculty of Science
m.a.dona@umail.leidenuniv.nl | 071 5272727
-
Annelies Schulte NordholtFaculty of Humanities
a.e.schulte@hum.leidenuniv.nl | +31 71 527 2170
-
Special Rapporteur visits Leiden: ‘Suspend the supply of arms to the warring parties’
Francesca Albanese, UN Special Rapporteur for human rights in the occupied Palestinian territories, visited Leiden Law School on 8 December within the scope of International Human Rights Day.
-
Laura de JongFaculty of Science
l.m.de.jong@lacdr.leidenuniv.nl | 071 5272727
-
A future with tailored therapy for patients with atherosclerosis
The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.
-
Erik DanenFaculty of Science
e.danen@lacdr.leidenuniv.nl | +31 71 527 4486
-
Marcel KeurentjesFaculty of Humanities
m.keurentjes@hum.leidenuniv.nl | 071 5272727
-
Claire VergerioSocial & Behavioural Sciences
c.vergerio@fsw.leidenuniv.nl | 071 5272727